These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8139487

  • 1. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
    Ghizzoni L, Bernasconi S, Virdis R, Vottero A, Ziveri M, Volta C, Iughetti L, Giovannelli G.
    Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
    [Abstract] [Full Text] [Related]

  • 2. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 3. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L, Cappa M, Vottero A, Ubertini G, Carta D, Di Iorgi N, Gasco V, Marchesi M, Raggi V, Ibba A, Napoli F, Massimi A, Maghnie M, Loche S, Porzio O.
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [Abstract] [Full Text] [Related]

  • 4. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R.
    J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous cortisol and growth hormone secretion interactions in patients with nonclassic 21-hydroxylase deficiency (NCCAH) and control children.
    Ghizzoni L, Mastorakos G, Vottero A, Magiakou MA, Chrousos GP, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):482-7. PubMed ID: 8636254
    [Abstract] [Full Text] [Related]

  • 6. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW, New MI.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [Abstract] [Full Text] [Related]

  • 7. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
    Sarafoglou K, Himes JH, Lacey JM, Netzel BC, Singh RJ, Matern D.
    Horm Res Paediatr; 2011 Jan; 75(1):19-25. PubMed ID: 20798478
    [Abstract] [Full Text] [Related]

  • 8. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB, Chasalow FI, Blethen SL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [Abstract] [Full Text] [Related]

  • 9. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K, Bidlingmaier F, Knorr D.
    Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
    [Abstract] [Full Text] [Related]

  • 10. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 11. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM, Mayes DM.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [Abstract] [Full Text] [Related]

  • 12. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 13. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
    Sólyom J, Gács G, Keszei K, Láng K, Orley J, Petheö I, Ságodi L.
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
    [Abstract] [Full Text] [Related]

  • 14. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
    Hampl R, Foretová L, Sulcová J, Stárka L.
    Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
    [Abstract] [Full Text] [Related]

  • 15. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F.
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [Abstract] [Full Text] [Related]

  • 16. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW.
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [Abstract] [Full Text] [Related]

  • 17. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980 Jul; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 18. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 19. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 20. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ, Yong AB, Warne GL, Montalto J.
    J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.